{'fraction_non_alphanumeric': 0.05424769703172978, 'fraction_numerical': 0.07471852610030706, 'mean_word_length': 4.556818181818182, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Tyrosinase Inhibitory Activity of Pyrazole Derivatives

A series of 3,5-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives were synthesized. Their structures were determined on the basis of spectroscopic data interpretation and their tyrosinase inhibitory activity was determined. The results showed that compound 2 (at 1.00 mg/mL) exhibits significant tyrosinase inhibitory activity with % inhibition of 91.866 ± 2.086 with L-tyrosine as substrate whereas compound 3 (at 1.00 mg/mL) exhibits significant tyrosinase inhibitory activity with % inhibition of 79.266 ± 0.552 and 89.593 ± 1.015 with L-tyrosine and L-DOPA as substrates. The IC50 values of compounds 2 and 3 were further determined comparing with kojic acid and resveratrol. It was found that IC50 values of compounds 2 and 3 were 0.391 ± 0.017 and 0.259 ± 0.005 mg/mL., with L-tyrosine as substrate, which were lower than those of the standard tyrosinase inhibitory resveratrol (0.965 ± 0.016 mg/mL).